Aspen Neuroscience, Inc. (ASPE) shareholders
ASPEPharmaceutical PreparationsFiscal year ends December 31
$14.89+14.88 (+148800.00%)
Close on Oct 30, 2026Market cap –P/E –Yield –
Ownership
Who owns Aspen Neuroscience's shares
No ownership filings found
No 13F institutional holdings, fund holdings, Schedule 13D/13G, or insider filings (Forms 3, 4, 5 and 144) are on record for ASPE.